Luís Pereira de Almeida is a prominent researcher in gene/molecular therapy for the Central Nervous System, with a focus on neurodegenerative diseases. He published an influential paper in 2002 demonstrating the use of lentiviral vectors to create in vivo models of diseases like Huntington’s, Parkinson’s, and Machado-Joseph’s disease. He is a professor at the Faculty of Pharmacy, University of Coimbra, where he teaches at both graduate and undergraduate levels. He also serves as the principal investigator and President of the Center for Neuroscience and Cell Biology at the university.
In addition to his research work, de Almeida has mentored numerous postdoctoral fellows and PhD students. He has secured funding for multiple research projects from various sources, including the Portuguese Foundation for Science and Technology and international collaborations such as the Marie Curie Initial Training Network “TreatPolyQ.” His group has also participated in several European network projects.